Organisation paid for research Program year 2025 Source: CMS Open Payments

Axces Research

Neither a doctor nor a teaching hospital

Research payments

$1,039,046

34 payments

Through program year 2025, Axces Research is reported as receiving $1,039,046 in research payments, across 34 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$8,532	20
2024	Research	$13,356	3
2023	Research	$605,365	4
2022	Research	$411,794	7

Breakdown

Who paid Research payments · program years 2022–2025

Merck Sharp & Dohme Corporation $1,030,514 14 payments
Pfizer Inc. $8,532 20 payments

Studies the money was for Research payments · program years 2022–2025

A Phase 3 Randomized, Double-blind, Active Comparator-controlled, Lot-to-Lot Consistency Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Adults 18 to 49 Years of Age $519,926 8 payments
A Phase 3 Randomized, Double-blind, Placebo-Controlled Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 When Administered Concomitantly with Influenza Vaccine in Adults 50 Years of Age or Older $510,588 6 payments
A Phase 3 Randomized Doubleblind Placebocontrolled Clinical Study Evaluating the Safety Tolerability Immunogenicity and Efficacy of A Variantadapted Bnt162b2 Vaccine in Healthy Participants 50 Through 64 Years of Age $8,532 20 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.